Emergency Medicine

Keith Ellis, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin Brener, MD
Director, Angiography Core Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Sorin Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail breners@ccf.org

Keith Ellis, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin Brener, MD
Director, Angiography Core Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Sorin Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail breners@ccf.org

Keith Ellis, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin Brener, MD
Director, Angiography Core Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Address: Sorin Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail breners@ccf.org

Raed H. Abdelhadi, MD
Department of Internal Medicine, The Cleveland Clinic

Curtis M. Rimmerman, MD
Head, Section of Clinical Electrocardiography, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Curtis M. Rimmerman, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail: rimmerc@ccf.org

Raed H. Abdelhadi, MD
Department of Internal Medicine, The Cleveland Clinic

Curtis M. Rimmerman, MD
Head, Section of Clinical Electrocardiography, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Curtis M. Rimmerman, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail: rimmerc@ccf.org

Raed H. Abdelhadi, MD
Department of Internal Medicine, The Cleveland Clinic

Curtis M. Rimmerman, MD
Head, Section of Clinical Electrocardiography, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Curtis M. Rimmerman, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, e-mail: rimmerc@ccf.org

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jaffera@ccf.org

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jaffera@ccf.org

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jaffera@ccf.org

Maxim D. Hammer, MD
Department of Neurology, The Cleveland Clinic

Derk W. Krieger, MD, PhD
Section of Stroke and Neurologic Intensive Care, Department of Neurology, The Cleveland Clinic; Co-principal investigator, Cooling for Acute Ischemic Brain Damage (COOL AID) study

Address: Derk W. Krieger, MD, PhD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kreiged@ccf.org

Dr. Krieger has indicated that he has received grant or research support from Radiant Medical Inc, is a consultant for Medcool, Inc, and is on the speakers’ bureaus of Sanofi-Synthelabo and the Bristol-Myers Squibb Company.

This paper discusses treatment that is not approved by the US Food and Drug Administration for the use under discussion.

Maxim D. Hammer, MD
Department of Neurology, The Cleveland Clinic

Derk W. Krieger, MD, PhD
Section of Stroke and Neurologic Intensive Care, Department of Neurology, The Cleveland Clinic; Co-principal investigator, Cooling for Acute Ischemic Brain Damage (COOL AID) study

Address: Derk W. Krieger, MD, PhD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kreiged@ccf.org

Dr. Krieger has indicated that he has received grant or research support from Radiant Medical Inc, is a consultant for Medcool, Inc, and is on the speakers’ bureaus of Sanofi-Synthelabo and the Bristol-Myers Squibb Company.

This paper discusses treatment that is not approved by the US Food and Drug Administration for the use under discussion.

Maxim D. Hammer, MD
Department of Neurology, The Cleveland Clinic

Derk W. Krieger, MD, PhD
Section of Stroke and Neurologic Intensive Care, Department of Neurology, The Cleveland Clinic; Co-principal investigator, Cooling for Acute Ischemic Brain Damage (COOL AID) study

Address: Derk W. Krieger, MD, PhD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail kreiged@ccf.org

Dr. Krieger has indicated that he has received grant or research support from Radiant Medical Inc, is a consultant for Medcool, Inc, and is on the speakers’ bureaus of Sanofi-Synthelabo and the Bristol-Myers Squibb Company.

This paper discusses treatment that is not approved by the US Food and Drug Administration for the use under discussion.

Anthony J. Furlan, MD
Medical Director, Cerebrovascular Center, Section of Stroke and Neurocritical Care, Department of Neurology, The Cleveland Clinic Foundation

Address: Anthony J. Furlan, MD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Furlan has indicated that he has received grant or research support from the Possis corporation, serves as a consultant for the Abbott and Lilly corporations, and is on the speakers’ bureau of the Bristol-Myers Squibb corporation.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Anthony J. Furlan, MD
Medical Director, Cerebrovascular Center, Section of Stroke and Neurocritical Care, Department of Neurology, The Cleveland Clinic Foundation

Address: Anthony J. Furlan, MD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Furlan has indicated that he has received grant or research support from the Possis corporation, serves as a consultant for the Abbott and Lilly corporations, and is on the speakers’ bureau of the Bristol-Myers Squibb corporation.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Anthony J. Furlan, MD
Medical Director, Cerebrovascular Center, Section of Stroke and Neurocritical Care, Department of Neurology, The Cleveland Clinic Foundation

Address: Anthony J. Furlan, MD, Department of Neurology, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Furlan has indicated that he has received grant or research support from the Possis corporation, serves as a consultant for the Abbott and Lilly corporations, and is on the speakers’ bureau of the Bristol-Myers Squibb corporation.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Teresa L. Carman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, and Head, Section of Hematology and Coagulation Medicine, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail deitchs@ccf.org

Teresa L. Carman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, and Head, Section of Hematology and Coagulation Medicine, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail deitchs@ccf.org

Teresa L. Carman, MD
Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, and Head, Section of Hematology and Coagulation Medicine, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail deitchs@ccf.org

James L. Orford, MBCHB, MPH
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Peter B. Berger, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Address: Peter Berger, MD, Division of Cardiovascular Diseases, Mayo Clinic, W16, 200 First Street SW, Rochester, MN 55905; e-mail berger.peter@mayo.edu.

James L. Orford, MBCHB, MPH
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Peter B. Berger, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Address: Peter Berger, MD, Division of Cardiovascular Diseases, Mayo Clinic, W16, 200 First Street SW, Rochester, MN 55905; e-mail berger.peter@mayo.edu.

James L. Orford, MBCHB, MPH
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Peter B. Berger, MD
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minn

Address: Peter Berger, MD, Division of Cardiovascular Diseases, Mayo Clinic, W16, 200 First Street SW, Rochester, MN 55905; e-mail berger.peter@mayo.edu.